Keywords
breast cancer
incidence in men
diagnosis
How to Cite
Abstract
This study evaluated the epidemiological, clinical, diagnostic and treatment aspects of breast cancer in men, which is rarely frequent and few investigations are reported in the literature. We looked over the scientific publications in databases such as BIREME - Virtual Health Library that allows the access to the Lilacs (Latin-American and Caribbean Health Sciences Literature), and also to the database PUBMED (National Library of Medicine U.S.). The breast cancer represents less than 1% of all cancers in males, nevertheless the occurrence of this cancer tends to increase due to poor quality of life and difficulty in performing an early diagnosis. Its incidence significantly increased from 0.86 to 1.06 per 100,000 men over the past 26 years. The highest rates are found in North America and Europe and the lowest rates in Asia. It is known that men have overall the worst rates of survival when compared to women, probably due to the breast cancer diagnosis in men being done when they are older, just at time of much more advanced disease stage, and also owing to the death rates by co-morbid diseases. The accurate diagnosis and prevention are the best strategies to make an improvement upon life quality and survival of patient with this malignancy.
References
1. Perkins GH, Middleton LP. Breast cancer in men. BMJ. 2003;327:239–40.
2. Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:20–6.
3. Aydin H., Gökbayir H., Tezcaner T, Zorlutuna Y. Combined surgery for ischemic heart disease and breast cancer in a male: a case report. Anadolu Kardiyol Derg, 2006;6:83-4.
4. Sinha S, Hughes RG, Ryley NG. Papillary carcinoma in a male breast cyst: a diagnostic challenge. Ann R Coll Surg Engl. 2006;88:1-3.
5. Giordano SH. A Review of the Diagnosis and Management of Male Breast Cancer. The Oncologist. 2005;10(7):471-9.
6. Leme LHS, Souza GA. Câncer de Mama em Homens: Aspectos Epidemiológicos, Clínicos e Terapêuticos. Rev Cienc Med. 2006; 5(15):391-8.
7. Chodick G, Struewing JP, Ron E, Rutter JL, Iscovich J. Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and Non-Ashkenazi men with breast cancer: Evidence from 261 cases in Israel, 1976-1999. Eur J Med Genet. 2008; 51(2):141-7.
8. Miolo G, Puppa LD, Santarosa M, Giacomi C, Veronesi A, Bidoli E, et al. Phenotypic features and genetic characterization of male breast. Bmc Câncer. 2006;6(156):1-9.
9. Palli D, Falchetti M, Masala G, Lupi R, Sera F, Saieva C, et al. Association between the BRCA2 N372H variant and male breast cancer risk: a population-based case-control study in Tuscany, Central Italy. BMC Cancer. 2007;7:170.
10. Diez JO, Cortes M, Domenech C, Pericay J, Brunet C, Alonso & M. Baiget. BRCA2 germ-line mutations in Spanish male breast cancer patients. Annals of Oncology, Barcelona, Spain. 2000;11:81-4.
11. Tai YC, Domchek S, Parmigiani G, Chen S. Breast Cancer Risk Among Male BRCA1 and BRCA2 Mutation. J Natl Cancer Inst. 2007;99(23):1811-4.
12. Contractor KB, Kaur K, Rodrigues, G, Kulkarni DM, Singhal H. Male breast cancer: is the scenario changing. World Journal Of Surgical Oncology. 2008;6(58):1-2.
13. O’Malley CD, Prehn AW, Shema SJ, Glaser SL. Racial/ethnic differences in survival rates in a population-based series of men with breast carcinoma. Cancer. 2002;94:2836–43.
14. Crew KD, Neugut AI, Wang X, Jacobson JS, Grann VR, Raptis G, et al. Racial Disparities in Treatment and Survival of Male Breast Cancer. Journal of Clinical Oncology. 2007;25(9):1089-98.
15. Nahleh Z, Srikantiah R, Safa M, Jazieh AR, Muhleman A, Komrokji R. Male breast cancer in the veteren affairs population: a comparative analysis. Cancer. 2007;109:1471–7.
16. Araújo RRF, Filho ASSF, Costa LO, Santos ALG, Galvão EL, Simplício LM. Câncer de mama em homens: estudo de 13 casos. Rev Bras Mast. 2003;13(5):115-21.
17. Giodarno SH, Buzdar AU, Hortobagyl GN. Breast Cancer in Men. Annals Of Internal Medicine. 2002;137(8):678-87.
18. Smolin Y, Massie MJ. Male Breast Cancer: A Review of the Literature and a Case Report. Psychosomatics. 2002;43:326-30.
19. Gentilini O, Chagas E, Zurrida S, Intra M, Cicco C, Gatti G, et al. Sentinel Lymph Node Biopsy in Male Patients with Early Breast Cancer. The Oncologist. 2007;12:512-5.
20. Araújo DB, Gomes NH , Renck DV, Silva RB, Oliveira DS, Vieira FEN. Metástases pulmonares em homem: localização incomum do tumor primário. J Bras Pneum. 2006;33(2):234-7.
21. Miranda TCC, Meirelles DSP. Receptores hormonais negativos em carcinoma de mama masculina: relato de caso. Rev Bras Mast. 2003;13(1);45-8.
22. Peschos D, Tsanou E, Dallas P, Charalabopoulos K, Kanaris C, Batistatou A. Mucinous breast carcinoma presenting as Paget’s disease of the nipple in a man: A case report. Diagn Pathol. 2008;3(42):1-4.
23. Rai B, Ghoshal S, Sharma SC. Breast cancer in males: A PGIMER experience . J Can Res Ther. 2005;1:31-3.
24. Gu GL, Wang SL, Wei XM, Ren L, Zou FX. Axillary metastasis as the first manifestation of male breast cancer: a case report. Cases Journal. 2008;1(285):1-4.
25. Ron E, Ikeda T, Preston DL ; Tokuoka, S. Male Breast Cancer Incidence Among Atomic Bomb Survivors. JNCI Journal of the National Cancer Institute. 2005; 97:603-5.
26. Erhan Y, Zekioglu O, Erhan Y. Invasive lobular carcinoma of the male breast. Can J Surg. 2006;49(5):365-6.
27. Chen L, Chantra PK, Larsen LH, Barton P, Rohitopakarn M, Zhu EQ. et al. Imaging Characteristics of Malignant Lesions of the Male Breast. Radiographics. 2006;26(4):993-1006.
28. Park S, Kim JH, Koo J, Park BW, Lee KS. Clinicopathological Characteristics of Male Breast Cancer. Yonsei Med J. 2008; 6(49):978-6.
29. Ioka A, Tsukuma H, Ajiki W, Oshima A. Survival of Male Breast Cancer Patients: A Population-Based Study. Jpn J Clin Oncol. 2006;11(36):699-703.
30. Arendt LM, Schuler LA. Prolactin Drives Estrogen Receptor-α-Dependent. The American Journal Of Pathology. 2008;172(1):194-202.
31. Dimitrov NV, Colucci P, Nagpal S. Some Aspects of the Endocrine Profi le and Management of Hormone-Dependent Male Breast Cancer. The Oncologist. 2007;7(12):798-807.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2009 Instituto Adolfo Lutz Journal